Akebia Therapeutics (AKBA)
(Delayed Data from NSDQ)
$1.10 USD
+0.01 (0.92%)
Updated May 24, 2024 04:00 PM ET
After-Market: $1.09 -0.01 (-0.91%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/23/24 |
---|---|
Current Quarter | -0.07 |
EPS Last Quarter | -0.09 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.28 |
Next Year | -0.23 |
EPS (TTM) | -0.23 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 47.18M | 46.12M | 185.77M | 147.07M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 48.75M | 46.29M | 191.06M | 168.24M |
Low Estimate | 45.61M | 45.95M | 180.47M | 125.90M |
Year ago Sales | 56.38M | 42.05M | 194.75M | 185.77M |
Year over Year Growth Est. | -16.32% | 9.68% | -4.61% | -20.83% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.07 | -0.08 | -0.28 | -0.23 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.08 | -0.10 | -0.34 | -0.54 |
High Estimate | -0.06 | -0.06 | -0.22 | 0.08 |
Low Estimate | -0.08 | -0.10 | -0.34 | -0.54 |
Year ago EPS | -0.06 | -0.08 | -0.28 | -0.28 |
Year over Year Growth Est. | -16.67% | 0.00% | 0.00% | 17.86% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.07 | -0.08 | -0.28 | -0.23 |
7 Days Ago | -0.07 | -0.08 | -0.28 | -0.23 |
30 Days Ago | -0.07 | -0.08 | -0.28 | -0.19 |
60 Days Ago | -0.07 | -0.08 | -0.27 | -0.19 |
90 Days Ago | -0.07 | -0.08 | -0.29 | -0.15 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.07 | -0.08 | -0.22 | 0.08 |
Zacks Consensus Estimate | -0.07 | -0.08 | -0.28 | -0.23 |
Earnings ESP | 0.00% | 0.00% | 21.43% | 134.78% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.09 | 0.00 | -0.08 | -0.06 | NA |
Estimate | -0.09 | -0.05 | -0.09 | -0.03 | NA |
Difference | 0.00 | 0.05 | 0.01 | -0.03 | 0.01 |
Surprise | 0.00% | 100.00% | 11.11% | -100.00% | 2.78% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more